HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

José Pedro De La Cruz Selected Research

José Pedro De La Cruz Research Topics

Disease

7Hypoxia (Hypoxemia)
03/2022 - 12/2008
3Experimental Diabetes Mellitus
11/2021 - 11/2016
2Diabetes Mellitus
11/2021 - 03/2010
2Diabetic Retinopathy (Retinopathy, Diabetic)
01/2018 - 03/2004
2Stroke (Strokes)
01/2006 - 01/2004
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2021
1Proteinuria
11/2021
1Ischemic Stroke
03/2010
1Brain Ischemia (Cerebral Ischemia)
01/2006
1Hemorrhage
01/2006
1Microaneurysm
03/2004
1Ischemia
03/2004
1Vitreous Hemorrhage
03/2004

Drug/Important Bio-Agent (IBA)

8Neuroprotective AgentsIBA
03/2022 - 01/2006
73,4-dihydroxyphenylethanol (hydroxytyrosol)IBA
11/2021 - 12/2008
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2010 - 01/2004
2Retinaldehyde (Retinal)IBA
03/2022 - 03/2004
2Olive OilIBA
11/2021 - 03/2010
2AntioxidantsIBA
11/2021 - 07/2015
2Biomarkers (Surrogate Marker)IBA
01/2018 - 11/2016
1PolyphenolsIBA
11/2021
1CreatinineIBA
11/2021
14-hydroxyphenylethanolIBA
07/2015
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2012
1Complement System Proteins (Complement)IBA
04/2012
1Interleukin-10 (Interleukin 10)IBA
04/2012
1Pharmaceutical PreparationsIBA
03/2010
1Acetates (Acetic Acid Esters)FDA Link
12/2008
1triflusalIBA
01/2006
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
03/2004
1Blood Glucose (Blood Sugar)IBA
03/2004

Therapy/Procedure

2Oral Administration
11/2021 - 12/2013
1Secondary Prevention
03/2010
1Vitrectomy
03/2004